| 29665672 | Regulatory Network of ARF in Cancer Development. | Mol Cells | 2018 May 31 | Ko A | doi: 10.14348/molcells.2018.0100 |
| 14749371 | Invasion of normal human fibroblasts induced by v-Fos is independent of proliferation, immortalization, and the tumor suppressors p16INK4a and p53. | Mol Cell Biol | 2004 Feb | Scott LA | - |
| 26318587 | Centrosome aberrations in human mammary epithelial cells driven by cooperative interactions between p16INK4a deficiency and telomere-dependent genotoxic stress. | Oncotarget | 2015 Sep 29 | Dom??nguez D | doi: 10.18632/oncotarget.4958. |
| 22490850 | [Expression of multiple tumor suppressor gene p16 and its relationship with prognosis of gastric cancer patients]. | Zhonghua Zhong Liu Za Zhi | 2012 Jan | Ma JM | - |
| 23804521 | Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients. | Head Neck | 2014 Aug | Pierini S | doi: 10.1002/hed.23413 |
| 18807517 | [Correlation of p16/INK4a gene damages and protein expression in the tumor tissue of sporadic breast cancer]. | Arkh Patol | 2008 Jul-Aug | Nemtsova MV | - |
| 15450420 | Overexpression of p16INK4a correlates with high expression of p73 in breast carcinomas. | Mutat Res | 2004 Oct 4 | Garcia V | - |
| 26999279 | Relationships between p14ARF Gene Methylation and Clinicopathological Features of Colorectal Cancer: A Meta-Analysis. | PLoS One | 2016 Mar 21 | Zhou Z | doi: 10.1371/journal.pone.0152050 |
| 17672936 | [Expression and significance of P16INK4A and PTEN in high-risk human papillomavirus-related cervical cancer]. | Ai Zheng | 2007 May | Zhao XL | - |
| 18245468 | TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases. | Cancer Res | 2008 Feb 1 | Yarosh W | doi: 10.1158/0008-5472.CAN-07-5012. |
| 18413741 | Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. | Cancer Res | 2008 Apr 15 | Majid S | doi: 10.1158/0008-5472.CAN-07-2290. |
| 22960768 | Ink4-Arf locus in cancer and aging. | Wiley Interdiscip Rev Dev Biol | 2012 Sep-Oct | Sherr CJ | - |
| 22565003 | Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. | J Clin Oncol | 2012 Jun 10 | Gillison ML | doi: 10.1200/JCO.2011.38.4099 |
| 12632492 | Studies on microsatellite instability in p16 gene and expression of hMSH2 mRNA in human gastric cancer tissues. | World J Gastroenterol | 2003 Mar | Zhang QX | - |
| 25891176 | Effects of emodin on the demethylation of tumor-suppressor genes in pancreatic cancer PANC-1 cells. | Oncol Rep | 2015 Jun | Zhang H | doi: 10.3892/or.2015.3914 |
| 15985168 | Alterations of tumor suppressor gene p16INK4a in pancreatic ductal carcinoma. | BMC Gastroenterol | 2005 Jun 28 | Attri J | - |
| 15809712 | Methylation and expression of p16INK4 tumor suppressor gene in primary colorectal cancer tissues. | Int J Oncol | 2005 May | Kim BN | - |
| 22049925 | Tumor suppressor p16INK4a controls oncogenic K-Ras function in human pancreatic cancer cells. | Cancer Sci | 2012 Feb | Rabien A | doi: 10.1111/j.1349-7006.2011.02140.x |
| 23645774 | P14ARF is down-regulated during tumour progression and predicts the clinical outcome in human breast cancer. | Anticancer Res | 2013 May | Wazir U | - |
| 20682398 | Gene methylation of SFRP2, P16, DAPK1, HIC1, and MGMT and KRAS mutations in sporadic colorectal cancer. | Cancer Genet Cytogenet | 2010 Sep | Pehlivan S | doi: 10.1016/j.cancergencyto.2010.05.019. |
| 27429046 | Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer. | Oncotarget | 2016 Aug 9 | Li S | doi: 10.18632/oncotarget.10575. |
| 28617556 | Correlation between methylation of the p16 promoter and cervical cancer incidence. | Eur Rev Med Pharmacol Sci | 2017 May | Wang FL | - |
| 29571246 | Hsa_circ_0014717 is downregulated in colorectal cancer and inhibits tumor growth by promoting p16 expression. | Biomed Pharmacother | 2018 Feb | Wang F | doi: 10.1016/j.biopha.2018.01.015 |
| 30136875 | CDKN2A Depletion Causes Aneuploidy and Enhances Cell Proliferation in Non-Immortalized Normal Human Cells. | Cancer Invest | 2018 | H??lias-Rodzewicz Z | doi: 10.1080/07357907.2018.1491588 |
| 23894465 | p16 Stimulates CDC42-dependent migration of hepatocellular carcinoma cells. | PLoS One | 2013 Jul 24 | Chen YW | doi: 10.1371/journal.pone.0069389 |
| 17967182 | Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma. | Mol Cancer | 2007 Oct 29 | Tsou JA | - |
| 15197677 | [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma]. | Laryngorhinootologie | 2004 Jun | Koscielny S | - |
| 17970082 | P16 methylation in serum as a potential marker for the malignancy of colorectal carcinoma. | Anticancer Res | 2007 Sep-Oct | Nakayama G | - |
| 12362979 | Expression of p16 in sporadic primary uveal melanoma. | Acta Biochim Pol | 2002 | Lamperska K | - |
| 27323397 | GLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARF. | Oncotarget | 2017 Mar 7 | Lee S | doi: 10.18632/oncotarget.9957. |
| 22751126 | p16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts. | Oncogene | 2013 May 2 | Al-Ansari MM | doi: 10.1038/onc.2012.270 |
| 21820152 | Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma. | Hum Pathol | 2012 Feb | Brankley SM | doi: 10.1016/j.humpath.2011.04.018 |
| 19801173 | Genome integrity: linking pluripotency and tumorgenicity. | Trends Genet | 2009 Oct | Deng W | doi: 10.1016/j.tig.2009.09.004 |
| 18676825 | COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells. | Cancer Res | 2008 Aug 1 | Mroz EA | doi: 10.1158/0008-5472.CAN-08-1279. |
| 25611240 | The Loss of p16 Expression Worsens the Prognosis of OSCC. | Appl Immunohistochem Mol Morphol | 2015 Nov-Dec | P??rez-Say??ns M | doi: 10.1097/PAI.0000000000000133. |
| 24525025 | ARF tumor suppression in the nucleolus. | Biochim Biophys Acta | 2014 Jun | Maggi LB Jr | doi: 10.1016/j.bbadis.2014.01.016 |
| 12149228 | ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma. | Blood | 2002 Aug 15 | Grnbaek K | - |
| 20307196 | p16 Modulates VEGF expression via its interaction with HIF-1alpha in breast cancer cells. | Cancer Invest | 2010 Jul | Zhang J | doi: 10.3109/07357900903286941. |
| 12359767 | Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. | Cancer Res | 2002 Oct 1 | Uhrbom L | - |
| 27494112 | Expression profiles of MGMT, p16, and APC genes in tumor and matching surgical margin from patients with oral squamous cell carcinoma. | Acta Biochim Pol | 2016 | Strzelczyk JK | doi: 10.18388/abp.2015_1204 |
| 15796965 | Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16. | Cancer Genet Cytogenet | 2005 Apr 15 | Kuroda H | - |
| 17923752 | Hypermethylation of p16INK4a in Korean non-small cell lung cancer patients. | J Korean Med Sci | 2007 Sep | Hong YS | - |
| 22534780 | Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers. | J Natl Cancer Inst | 2012 Jun 20 | Mukherjee B | doi: 10.1093/jnci/djs221 |
| 21488187 | Overexpressions of Cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications. | Yonsei Med J | 2011 May | Chae SW | doi: 10.3349/ymj.2011.52.3.445. |
| 17881001 | Dissection of protein-protein interaction and CDK4 inhibition in the oncogenic versus tumor suppressing functions of gankyrin and P16. | J Mol Biol | 2007 Nov 2 | Mahajan A | - |
| 22120712 | Abnormal MDMX degradation in tumor cells due to ARF deficiency. | Oncogene | 2012 Aug 9 | Li X | doi: 10.1038/onc.2011.534 |
| 18951899 | p16INK4a is a beta-catenin target gene and indicates low survival in human colorectal tumors. | Gastroenterology | 2009 Jan | Wassermann S | doi: 10.1053/j.gastro.2008.09.019 |
| 12532425 | Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene. | Int J Cancer | 2003 Mar 10 | Sakano S | - |
| 25765380 | The Fidelity of p16 Staining as a Surrogate Marker of Human Papillomavirus Status in Fine-Needle Aspirates and Core Biopsies of Neck Node Metastases: Implications for HPV Testing Protocols. | Acta Cytol | 2015 | Holmes BJ | doi: 10.1159/000375148 |
| 26059208 | No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression. | Eur Arch Otorhinolaryngol | 2016 Jul | Maquieira R | doi: 10.1007/s00405-015-3675-9 |
| 18760195 | p16 gene expression in basal cell carcinoma. | Arch Med Res | 2008 Oct | Eshkoor SA | doi: 10.1016/j.arcmed.2008.06.003. |
| 27444279 | p16 upregulation is linked to poor prognosis in ERG negative prostate cancer. | Tumour Biol | 2016 Sep | Burdelski C | - |
| 17658461 | Identification and characterization of a novel protein ISOC2 that interacts with p16INK4a. | Biochem Biophys Res Commun | 2007 Sep 21 | Huang X | - |
| 12152785 | Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms. | J Neuropathol Exp Neurol | 2002 Aug | Perry A | - |
| 15355988 | p14 Arf promotes small ubiquitin-like modifier conjugation of Werners helicase. | J Biol Chem | 2004 Nov 26 | Woods YL | - |
| 22521293 | ETS-dependent p16INK4a and p21waf1/cip1 gene expression upon endothelin-1 stimulation in malignant versus and non-malignant proximal tubule cells. | Life Sci | 2012 Oct 15 | von Brandenstein M | doi: 10.1016/j.lfs.2012.04.014 |
| 18817867 | Bmi1 promotes prostate tumorigenesis via inhibiting p16(INK4A) and p14(ARF) expression. | Biochim Biophys Acta | 2008 Nov | Fan C | doi: 10.1016/j.bbadis.2008.08.009 |
| 17201148 | Homozygous deletions of the INK4a/ARF locus in renal cell cancer. | Anticancer Res | 2006 Nov-Dec | Kasahara T | - |
| 26687648 | PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population. | Tumour Biol | 2016 Jun | Sushma PS | doi: 10.1007/s13277-015-4648-8 |
| 16211008 | Distinct E2F-mediated transcriptional program regulates p14ARF gene expression. | EMBO J | 2005 Nov 2 | Komori H | - |
| 20957490 | MTHFR C677T polymorphism and differential methylation status in gastric cancer: an association with Helicobacter pylori infection. | Virchows Arch | 2010 Dec | Neves Filho EH | doi: 10.1007/s00428-010-0996-3 |
| 24104554 | Potentially functional variants of p14ARF are associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy. | Carcinogenesis | 2014 Jan | Song X | doi: 10.1093/carcin/bgt336 |
| 20405295 | Expression of p16 protein and epidermal growth factor receptor in patients with adenocarcinoma of the uterine cervix: an immunohistochemical analysis. | Arch Gynecol Obstet | 2011 Mar | Bodner K | doi: 10.1007/s00404-010-1464-7 |
| 21108607 | Correlation of cell cycle regulatory proteins (p53 and p16(ink)(a)) and bcl-2 oncoprotein with mitotic index and thickness of primary cutaneous malignant melanoma. | Bosn J Basic Med Sci | 2010 Nov | Kostov M | - |
| 11908877 | Phenotypic changes associated with exogenous expression of p16INK4a in human glioma cells. | Brain Tumor Pathol | 2001 | Noguchi A | - |
| 19212341 | Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors. | J Invest Dermatol | 2009 Aug | Haferkamp S | doi: 10.1038/jid.2009.5 |
| 19258476 | CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis. | Cancer Epidemiol Biomarkers Prev | 2009 Mar | Vasilatos SN | doi: 10.1158/1055-9965.EPI-08-0875 |
| 15485902 | ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway. | Mol Cell Biol | 2004 Nov | Brady SN | - |
| 24440092 | Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age. | Hum Pathol | 2014 Mar | Liau JY | doi: 10.1016/j.humpath.2013.10.019 |
| 21849808 | Inactivation of COX-2, HMLH1 and CDKN2A gene by promoter methylation in gastric cancer: relationship with histological subtype, tumor location and Helicobacter pylori genotype. | Pathobiology | 2011 | Alves MK | doi: 10.1159/000329475 |
| 26338965 | miR-146b-5p mediates p16-dependent repression of IL-6 and suppresses paracrine procarcinogenic effects of breast stromal fibroblasts. | Oncotarget | 2015 Oct 6 | Al-Ansari MM | doi: 10.18632/oncotarget.4933. |
| 25224768 | Expressions of p16 and p27 in urothelial carcinoma and their prognostic value. | Kaohsiung J Med Sci | 2014 Sep | Yang CH | doi: 10.1016/j.kjms.2014.05.003 |
| 12009890 | Structural consequences of tumor-derived mutations in p16INK4a probed by limited proteolysis. | Biochemistry | 2002 May 21 | Zhang B | - |
| 18219279 | p14ARF hypermethylation is common but INK4a-ARF locus or p53 mutations are rare in Merkel cell carcinoma. | J Invest Dermatol | 2008 Jul | Lassacher A | doi: 10.1038/sj.jid.5701256 |
| 23887305 | The pathogenesis of atypical proliferative Brenner tumor: an immunohistochemical and molecular genetic analysis. | Mod Pathol | 2014 Feb | Kuhn E | doi: 10.1038/modpathol.2013.142 |
| 22883455 | [Expression and clinical values of HPV L1 and p16INK4a protein in uterine cervical lesions]. | Zhonghua Zhong Liu Za Zhi | 2012 May | Song Y | doi: 10 |
| 16699861 | Promoter methylation profile in gallbladder cancer. | J Gastroenterol | 2006 Mar | Roa JC | - |
| 23449974 | Up-regulation of survivin during immortalization of human myofibroblasts is linked to repression of tumor suppressor p16(INK4a) protein and confers resistance to oxidative stress. | J Biol Chem | 2013 Apr 26 | Kan CY | doi: 10.1074/jbc.M112.447821 |
| 12875969 | Co-expression of p16(INK4A) and laminin 5 gamma2 by microinvasive and superficial squamous cell carcinomas in vivo and by migrating wound and senescent keratinocytes in culture. | Am J Pathol | 2003 Aug | Natarajan E | - |
| 21797124 | P16 and retinoblastoma protein expression in endometrial carcinoma and clinical significance. | Eur J Gynaecol Oncol | 2011 | Koh VM | - |
| 18199527 | p53-Dependent and p53-independent activation of autophagy by ARF. | Cancer Res | 2008 Jan 15 | Abida WM | doi: 10.1158/0008-5472.CAN-07-2069. |
| 17369842 | p16INK4A-silencing augments DNA damage-induced apoptosis in cervical cancer cells. | Oncogene | 2007 Sep 6 | Lau WM | - |
| 15223748 | cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact. A study in non-small cell lung carcinomas. | Biotech Histochem | 2004 Feb | Evangelou K | - |
| 23803020 | Cyclin D1, retinoblastoma and p16 protein expression in carcinoma of the gallbladder. | Asian Pac J Cancer Prev | 2013 | Srivastava V | - |
| 24577117 | Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial. | Ann Oncol | 2014 Apr | Vermorken JB | doi: 10.1093/annonc/mdt574 |
| 16760301 | Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. | Ann Oncol | 2006 Jun | Bazan V | - |
| 19514363 | [Role of the tumor suppressor ARF in oncogenesis]. | Arkh Patol | 2009 Jan-Feb | Pimkina IuS | - |
| 24588771 | Inhibiting enhancer of zeste homolog 2 promotes cellular senescence in gastric cancer cells SGC-7901 by activation of p21 and p16. | DNA Cell Biol | 2014 Jun | Bai J | doi: 10.1089/dna.2014.2340 |
| 26330556 | Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor. | J Biol Chem | 2015 Oct 9 | Minges JT | doi: 10.1074/jbc.M115.663641 |
| 15547691 | Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas. | Int J Oncol | 2004 Dec | Bachmann IM | - |
| 26191206 | A neurogenic tumor containing a low-grade malignant peripheral nerve sheath tumor (MPNST) component with loss of p16 expression and homozygous deletion of CDKN2A/p16: a case report showing progression from a neurofibroma to a high-grade MPNST. | Int J Clin Exp Pathol | 2015 May 1 | Tajima S | - |
| 20568901 | Promoter methylation and expression changes of CDH1 and P16 genes in invasive breast cancer and adjacent normal breast tissue. | Neoplasma | 2010 | Celebiler Cavusoglu A | - |
| 12060387 | Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma. | J Invest Dermatol | 2002 Jun | Child FJ | - |
| 17850505 | Potent p53-independent tumor suppressor activity of ARF in melanoma-genesis. | Pigment Cell Res | 2007 Oct | Widlund HR | - |
| 20683001 | Methylation of the p16 gene is frequently detected in lymphatic-invasive gastric cancer. | Anticancer Res | 2010 Jul | Goto T | - |
| 22998186 | Emerging roles of mitochondrial p53 and ARF. | Curr Drug Targets | 2012 Dec | Itahana Y | - |
| 15582998 | p14ARF induces G2 cell cycle arrest in p53- and p21-deficient cells by down-regulating p34cdc2 kinase activity. | J Biol Chem | 2005 Feb 25 | Normand G | - |
| 17659731 | Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer. | World J Gastroenterol | 2007 Jul 21 | Salek C | - |
| 18202755 | Expression of p16INK4a and MIB-1 in relation to histopathology and HPV types in cervical adenocarcinoma. | Int J Oncol | 2008 Feb | Muller S | - |
| 19667129 | Real-time in vivo imaging of p16Ink4a reveals cross talk with p53. | J Cell Biol | 2009 Aug 10 | Yamakoshi K | doi: 10.1083/jcb.200904105. |
| 14585357 | Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. | Cancer Cell | 2003 Oct | Drayton S | - |
| 24503757 | p16 FISH deletion in surface epithelial mesothelial proliferations is predictive of underlying invasive mesothelioma. | Am J Surg Pathol | 2014 May | Hwang H | doi: 10.1097/PAS.0000000000000176. |
| 28068628 | Epoxy clerodane diterpene inhibits MCF-7 human breast cancer cell growth by regulating the expression of the functional apoptotic genes Cdkn2A, Rb1, mdm2 and p53. | Biomed Pharmacother | 2017 Mar | Subash-Babu P | doi: 10.1016/j.biopha.2016.12.091 |
| 14519636 | p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. | Clin Cancer Res | 2003 Sep 15 | Perrone F | - |
| 26575287 | The human ARF tumor suppressor senses blastema activity and suppresses epimorphic tissue regeneration. | Elife | 2015 Nov 17 | Hesse RG | doi: 10.7554/eLife.07702. |
| 11740049 | Inactivation of the p16 gene in human pituitary nonfunctioning tumors by hypermethylation is more common in null cell adenomas. | Endocr Pathol | 2001 Fall | Ruebel KH | - |
| 19131428 | Increased gamma-tubulin expression and P16INK4A promoter methylation occur together in preinvasive lesions and carcinomas of the breast. | Ann Oncol | 2009 Mar | Liu T | doi: 10.1093/annonc/mdn651 |
| 16447252 | TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. | J Cell Physiol | 2006 Jun | Augello C | - |
| 23727582 | Evidence that P12, a specific variant of P16(INK4A), plays a suppressive role in human pancreatic carcinogenesis. | Biochem Biophys Res Commun | 2013 Jun 28 | Poi MJ | doi: 10.1016/j.bbrc.2013.05.078 |
| 20861610 | Immunohistochemical expression of retinoblastoma protein and p16 in renal cell carcinoma. | Urol Int | 2011 | Maruschke M | doi: 10.1159/000320510 |
| 18779733 | p16 immunohistochemistry as an alternative marker to distinguish atypical lipomatous tumor from deep-seated lipoma. | Appl Immunohistochem Mol Morphol | 2009 Jan | He M | doi: 10.1097/PAI.0b013e3181719223. |
| 20015385 | Increased epithelial stem cell traits in advanced endometrial endometrioid carcinoma. | BMC Genomics | 2009 Dec 16 | Chang SJ | doi: 10.1186/1471-2164-10-613. |
| 21847682 | [Expression of the tumormarker p16INK4a in cytology specimens of the urinary bladder. A new means for early recognition and surveillance of urothelial cancer]. | Urologe A | 2011 Sep | Tauber S | doi: 10.1007/s00120-011-2693-5. |
| 19140325 | [Molecular-genetic analysis of clonal intratumoral heterogeneity on colorectal adenocarcinomas]. | Mol Biol (Mosk) | 2008 Nov-Dec | Nemtsova MN | - |
| 11830494 | p14(ARF) nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways. | Blood | 2002 Feb 15 | S??nchez-Aguilera A | - |
| 26283007 | Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial Carcinoma. | Sci Rep | 2015 Aug 18 | Su L | doi: 10.1038/srep13238. |
| 21942715 | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | J Proteome Res | 2011 Nov 4 | Lai Y | doi: 10.1021/pr200642c |
| 11861400 | Human tumor suppressor ARF impedes S-phase progression independent of p53. | Cancer Res | 2002 Feb 15 | Yarbrough WG | - |
| 12924440 | Hypermethylation of the CDKN2/p16INK4A promotor in thyroid carcinogenesis. | Pathol Res Pract | 2003 | Boltze C | - |
| 27333655 | Overexpression of p16(INK4a) in Mastocytosis (Urticarial Pigmentosa). | Fukuoka Igaku Zasshi | 2016 Jan | Tsujita J | - |
| 17936562 | Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer. | Cancer Cell | 2007 Oct | Mallakin A | - |
| 24046371 | Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines. | Proc Natl Acad Sci U S A | 2013 Oct 1 | McLaughlin-Drubin ME | doi: 10.1073/pnas.1310432110 |
| 23308265 | Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation. | PLoS One | 2013 | Vivo M | doi: 10.1371/journal.pone.0053631 |
| 18703154 | Interaction of p14ARF with Brca1 in cancer cell lines and primary breast cancer. | Cell Biol Int | 2008 Oct | He L | doi: 10.1016/j.cellbi.2008.07.018 |
| 24937448 | Anti-proliferative and pro-apoptotic activity of whole extract and isolated indicaxanthin from Opuntia ficus-indica associated with re-activation of the onco-suppressor p16(INK4a) gene in human colorectal carcinoma (Caco-2) cells. | Biochem Biophys Res Commun | 2014 Jul 18 | Naselli F | doi: 10.1016/j.bbrc.2014.06.029 |
| 12582152 | Oligomerization of the human ARF tumor suppressor and its response to oxidative stress. | J Biol Chem | 2003 May 23 | Men??ndez S | - |
| 20872974 | Loss of chromosome 9p21 and decreased p16 expression correlate with malignant gastrointestinal stromal tumor. | World J Gastroenterol | 2010 Oct 7 | Zhang Y | - |
| 20501856 | ARF suppresses tumor angiogenesis through translational control of VEGFA mRNA. | Cancer Res | 2010 Jun 1 | Kawagishi H | doi: 10.1158/0008-5472.CAN-10-0368 |
| 21880712 | Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. | J Biol Chem | 2011 Oct 21 | Copp?? JP | doi: 10.1074/jbc.M111.257071 |
| 24983247 | Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1. | PLoS One | 2014 Jul 1 | Choy E | doi: 10.1371/journal.pone.0101283 |
| 19331161 | Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer. | Anticancer Res | 2009 Jan | Goto T | - |
| 15897876 | CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. | Oncogene | 2005 Aug 25 | Bernard D | - |
| 26043844 | Comparative analysis of Rb1, P16 and ER as diagnostic, prognostic and potential targets for therapeutic agents in ovarian epithelial tumors: an immunohistochemical study of 130 ovarian carcinomas. | J Ovarian Res | 2015 Jun 5 | Ferguson DC | doi: 10.1186/s13048-015-0163-1. |
| 24161991 | CDK6 and p16INK4A in lymphoid malignancies. | Oncotarget | 2013 Nov | Kollmann K | - |
| 22667340 | Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma. | Acta Otolaryngol | 2012 Sep | Lundberg M | doi: 10.3109/00016489.2012.678944 |
| 25465729 | Influence of human papillomavirus and p16(INK4a) on treatment outcome of patients with anal cancer. | Radiother Oncol | 2014 Dec | Koerber SA | doi: 10.1016/j.radonc.2014.11.013 |
| 22925370 | Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing. | J Transl Med | 2012 Aug 27 | Bihl MP | doi: 10.1186/1479-5876-10-173. |
| 19618401 | Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids. | Int J Cancer | 2010 Jan 15 | Zhu W | doi: 10.1002/ijc.24728. |
| 25138050 | Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis. | Oncotarget | 2014 Aug 30 | Ortiz B | - |
| 21325273 | VentX trans-activates p53 and p16ink4a to regulate cellular senescence. | J Biol Chem | 2011 Apr 8 | Wu X | doi: 10.1074/jbc.M110.206078 |
| 21493295 | Loss of heterozygosity of tumor suppressor genes (p16, Rb, E-cadherin, p53) in hypopharynx squamous cell carcinoma. | Otolaryngol Head Neck Surg | 2011 Jul | Sang-Hyuk Lee SH | doi: 10.1177/0194599811401327. |
| 25752701 | p14(ARF) Prevents Proliferation of Aneuploid Cells by Inducing p53-Dependent Apoptosis. | J Cell Physiol | 2016 Feb | Veneziano L | doi: 10.1002/jcp.24976. |
| 18394558 | Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development. | Cancer Cell | 2008 Apr | Wiedemeyer R | doi: 10.1016/j.ccr.2008.02.010. |
| 26248224 | Effect of Iodine Intake on p14ARF and p16INK4a Expression in Thyroid Papillary Carcinoma in Rats. | Med Sci Monit | 2015 Aug 6 | Sun R | doi: 10.12659/MSM.893486. |
| 24382891 | Human Kruppel-related 3 (HKR3) is a novel transcription activator of alternate reading frame (ARF) gene. | J Biol Chem | 2014 Feb 14 | Yoon JH | doi: 10.1074/jbc.M113.526855 |
| 12199782 | Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival. | Br J Haematol | 2002 Sep | Mateos MV | - |
| 12091906 | The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. | Nat Med | 2002 Jul | Linggi B | - |
| 24136988 | The molecular balancing act of p16(INK4a) in cancer and aging. | Mol Cancer Res | 2014 Feb | LaPak KM | doi: 10.1158/1541-7786.MCR-13-0350 |
| 12046062 | Tumor suppressor gene p16 and Rb expression in gastric cardia precancerous lesions from subjects at a high incidence area in northern China. | World J Gastroenterol | 2002 Jun | Zhou Y | - |
| 19450526 | Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary. | Mol Cell | 2009 May 15 | Witcher M | doi: 10.1016/j.molcel.2009.04.001. |
| 15014024 | Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China. | Clin Cancer Res | 2004 Mar 1 | Ueki T | - |
| 25879218 | Molecular subtypes in stage II-III colon cancer defined by genomic instability: early recurrence-risk associated with a high copy-number variation and loss of RUNX3 and CDKN2A. | PLoS One | 2015 Apr 16 | Berg M | doi: 10.1371/journal.pone.0122391 |
| 19130399 | Analysis of pRb, p16INK4A proteins and proliferating antigens: PCNA, Ki-67 and MCM5 expression in aggressive fibromatosis (desmoid tumor). | Histol Histopathol | 2009 Mar | Stalinska L | doi: 10.14670/HH-24.299. |
| 20402675 | CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas. | APMIS | 2010 Apr | Alves MK | doi: 10.1111/j.1600-0463.2010.02591.x. |
| 16766534 | Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. | J Biol Chem | 2006 Aug 25 | Reynolds PA | - |
| 18931530 | MBD2-mediated transcriptional repression of the p14ARF tumor suppressor gene in human colon cancer cells. | Pathobiology | 2008 | Martin V | doi: 10.1159/000151708 |
| 26802432 | Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer. | Int J Cancer | 2016 Jul 1 | Inoue K | doi: 10.1002/ijc.30003 |
| 26686095 | Nuclear trafficking of EGFR by Vps34 represses Arf expression to promote lung tumor cell survival. | Oncogene | 2016 Jul 28 | Dayde D | doi: 10.1038/onc.2015.480 |
| 27597521 | Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry. | Hum Pathol | 2017 Jan | Kammerer-Jacquet SF | doi: 10.1016/j.humpath.2016.08.009 |
| 27989786 | Malignant tenosynovial giant cell tumor with CDKN2A/B genomic alteration: a histological, immunohistochemical, and molecular study. | Hum Pathol | 2017 May | Alexiev BA | doi: 10.1016/j.humpath.2016.12.003 |
| 28985506 | NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression. | Mol Cell | 2017 Oct 5 | Chen D | doi: 10.1016/j.molcel.2017.09.009. |
| 29030066 | Etoposide induced NMI promotes cell apoptosis by activating the ARF-p53 signaling pathway in lung carcinoma. | Biochem Biophys Res Commun | 2018 Jan 1 | Song D | doi: 10.1016/j.bbrc.2017.10.010 |
| 27356744 | MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo. | Oncotarget | 2016 Jul 26 | Xie Y | doi: 10.18632/oncotarget.10251. |
| 28515351 | Local immune response depends on p16INK4a status of primary tumor in vulvar squamous cell carcinoma. | Oncotarget | 2017 Jul 11 | Sznurkowski JJ | doi: 10.18632/oncotarget.17581. |
| 30236142 | Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma. | J Exp Clin Cancer Res | 2018 Sep 20 | Hsu CL | doi: 10.1186/s13046-018-0873-5. |
| 30264192 | Proliferation of aneuploid cells induced by CENP-E depletion is counteracted by the p14ARF tumor suppressor. | Mol Genet Genomics | 2019 Feb | Veneziano L | doi: 10.1007/s00438-018-1495-5 |
| 25064638 | Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling. | J Am Acad Dermatol | 2014 Nov | Potrony M | doi: 10.1016/j.jaad.2014.06.036 |
| 21302620 | Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma. | Tumori | 2010 Sep-Oct | Hu SL | - |
| 24259266 | KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer. | Int J Cancer | 2014 Jun 15 | Kohonen-Corish MR | doi: 10.1002/ijc.28619 |
| 24969958 | MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients. | Eur J Surg Oncol | 2014 Sep | Su CY | doi: 10.1016/j.ejso.2014.04.017 |
| 18714178 | Low prevalence of CDKN2A/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland. | Eur J Cancer Prev | 2008 Oct | Debniak T | doi: 10.1097/CEJ.0b013e3282f75eb1. |
| 24816738 | p16 Methylation is associated with chemosensitivity to fluorouracil in patients with advanced gastric cancer. | Med Oncol | 2014 Jun | Wang M | doi: 10.1007/s12032-014-0988-2 |
| 22860097 | p14ARF post-transcriptional regulation of nuclear cyclin D1 in MCF-7 breast cancer cells: discrimination between a good and bad prognosis? | PLoS One | 2012 | McGowan EM | doi: 10.1371/journal.pone.0042246 |
| 26416059 | Association of p16 gene methylation with prostate cancer risk: a meta-analysis. | J BUON | 2015 Jul-Aug | Feng W | - |
| 20195775 | Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families. | Fam Cancer | 2010 Sep | Slater EP | doi: 10.1007/s10689-010-9329-6. |
| 24240582 | A systematic review of hypermethylation of p16 gene in esophageal cancer. | Cancer Biomark | 2013 | Xu R | doi: 10.3233/CBM-130355. |
| 18418463 | p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer. | Mol Med | 2008 Jul-Aug | Wettergren Y | doi: 10.2119/2007-00096.Wettergren. |
| 27199504 | Prognostic and Clinicopathological Significance of Downregulated p16 Expression in Patients with Bladder Cancer: A Systematic Review and Meta-Analysis. | Dis Markers | 2016 | Gan X | doi: 10.1155/2016/5259602 |
| 28459370 | p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India. | Tumour Biol | 2017 May | Das M | doi: 10.1177/1010428317698384. |
| 28042030 | Ectopic expression of the CDK inhibitor p21Cip1 enhances deregulated E2F activity and increases cancer cell-specific cytotoxic gene expression mediated by the ARF tumor suppressor promoter. | Biochem Biophys Res Commun | 2017 Jan 29 | Kurayoshi K | doi: 10.1016/j.bbrc.2016.12.185 |
| 29561443 | Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer: A PRISMA-compliant Meta-analysis. | Medicine (Baltimore) | 2018 Mar | Zhou N | doi: 10.1097/MD.0000000000010195. |
| 28276595 | A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer. | J Clin Lab Anal | 2018 Jan | ShahidSales S | doi: 10.1002/jcla.22190 |
| 12670910 | Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. | Cancer Res | 2003 Apr 1 | Holst CR | - |
| 17297463 | ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2. | Oncogene | 2007 Jul 12 | Chang DL | - |
| 24336114 | S-phase kinase-associated protein 2 knockdown blocks colorectal cancer growth via regulation of both p27 and p16 expression. | Cancer Gene Ther | 2013 Dec | Xu SY | doi: 10.1038/cgt.2013.70 |
| 25207720 | Luteolin induces apoptosis in BE colorectal cancer cells by downregulating calpain, UHRF1, and DNMT1 expressions. | Nutr Cancer | 2014 | Krifa M | doi: 10.1080/01635581.2014.951729 |
| 26518891 | Association of NOTCH with different microRNAs in head and neck cancer. | Cell Mol Biol (Noisy-le-grand) | 2015 Oct 30 | Masood N | - |
| 23045280 | Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer. | Oncogene | 2013 Aug 29 | Maglic D | doi: 10.1038/onc.2012.423 |
| 23003335 | p16(INK4a) /Ki-67 dual labelling as a marker for the presence of high-grade cancer cells or disease progression in urinary cytopathology. | Cytopathology | 2013 Oct | Piaton E | doi: 10.1111/j.1365-2303.2012.01008.x |
| 16799478 | Immunohistochemical detection of p16INK4a in dysplastic lesions of the oral cavity. | Mod Pathol | 2006 Oct | Bradley KT | - |
| 14679123 | INK4/ARF germline alterations in pancreatic cancer patients. | Ann Oncol | 2004 Jan | Ghiorzo P | - |
| 19020940 | Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. | Ann Surg Oncol | 2009 Feb | Chen J | doi: 10.1245/s10434-008-0220-8 |
| 15998377 | Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women. | Pathol Int | 2005 Aug | Lin ZH | - |
| 21567202 | Association analysis of p16 (CDKN2A) and RB1 polymorphisms with susceptibility to cervical cancer in Indian population. | Mol Biol Rep | 2012 Jan | Thakur N | doi: 10.1007/s11033-011-0752-z |
| 15254707 | Hypermethylation of E-cadherin gene is frequent and independent of p16INK4A methylation in non-small cell lung cancer: potential prognostic implication. | Oncol Rep | 2004 Aug | Shimamoto T | - |
| 17393105 | Effects of exogenous p16(ink4a) gene on biological behaviors of human lung cancer cells. | J Huazhong Univ Sci Technolog Med Sci | 2007 Feb | Zhang X | - |
| 26118188 | Expression Analysis of p16, c-Myc, and mSin3A in Non-small Cell Lung Cancer by Computer Aided Scoring and Analysis (CASA). | Clin Lab | 2015 | Salmaninejad A | - |
| 20683150 | Frequency of P16INK4a and P14ARF genes methylation and its impact on bladder cancer cases in north Indian population. | Dis Markers | 2010 | Ali Hosseini S | doi: 10.3233/DMA-2010-0716. |
| 22368299 | CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. | J Med Genet | 2012 Mar | Ghiorzo P | doi: 10.1136/jmedgenet-2011-100281. |
| 23345170 | p16 expression in carcinoma of unknown primary: diagnostic indicator and prognostic marker. | Head Neck | 2013 Nov | Vent J | doi: 10.1002/hed.23190 |
| 21990227 | Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue. | Head Neck | 2011 Nov | Harris SL | doi: 10.1002/hed.21650 |
| 18830187 | Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa. | Med Sci Monit | 2008 Oct | Krakowczyk L | - |
| 20444664 | Alterations in p16 and p53 genes and chromosomal findings in patients with lung cancer: fluorescence in situ hybridization and cytogenetic studies. | Cancer Epidemiol | 2010 Aug | Demirhan O | doi: 10.1016/j.canep.2010.03.018 |
| 16115911 | Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype. | Clin Cancer Res | 2005 Aug 15 | Chapman EJ | - |
| 24122232 | Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer. | Tumour Biol | 2014 Mar | Zhang C | - |
| 17061045 | CDKN2A-positive breast cancers in young women from Poland. | Breast Cancer Res Treat | 2007 Jul | Debniak T | - |
| 16100943 | Effects of exogenous wild-type P16 gene transfection on the expression of cell cycle-related proteins in bladder cancer cell line. | Cancer Invest | 2005 | Li L | - |
| 11948103 | p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients. | Clin Cancer Res | 2002 Apr | Dom??nguez G | - |
| 15381905 | p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. | Int J Gynecol Pathol | 2004 Oct | Branca M | - |
| 20565749 | Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549. | J Exp Clin Cancer Res | 2010 Jun 17 | Zhang W | doi: 10.1186/1756-9966-29-74. |
| 20237870 | Overexpression of c-erbB-2 and loss of p16 have molecular diagnostic relevance but no prognostic value in lung cancer. | Med Oncol | 2011 Mar | Feng XL | doi: 10.1007/s12032-010-9452-0 |
| 23803092 | Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer. | Asian Pac J Cancer Prev | 2013 | Xiong HL | - |
| 19787243 | Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells. | Oncol Rep | 2009 Nov | Meng CF | - |
| 20473920 | Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review. | Int J Cancer | 2011 Mar 1 | Shima K | doi: 10.1002/ijc.25432. |
| 20010526 | Correlation between histological type and immunohistochemical profile of prostate cancer and gleason scale gradation. | Exp Oncol | 2009 Dec | Iemelynova AA | - |
| 24268095 | Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer. | Lung Cancer | 2014 Jan | Xiao P | doi: 10.1016/j.lungcan.2013.09.008 |
| 25910412 | P16INK4A and survivin: Diagnostic and prognostic markers in cervical intraepithelial neoplasia and cervical squamous cell carcinoma. | Exp Mol Pathol | 2015 Aug | Liu HQ | doi: 10.1016/j.yexmp.2015.04.004 |
| 25943250 | CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies. | Int J Cancer | 2015 Nov 1 | Helgadottir H | doi: 10.1002/ijc.29595 |
| 15455389 | Frequent p16INK4a promoter hypermethylation in human papillomavirus-infected female lung cancer in Taiwan. | Int J Cancer | 2005 Jan 20 | Wu MF | - |
| 15336553 | Restoration of protein synthesis in pancreatic cancer cells by trans-splicing ribozymes. | Biochem Biophys Res Commun | 2004 Sep 24 | Kastanos E | - |
| 26728668 | A meta-analysis of serum p16 gene promoter methylation for diagnosis of nonsmall cell lung cancer. | Indian J Cancer | 2015 Dec | Yan R | doi: 10.4103/0019-509X.172507. |
| 21830402 | Helicobacter pylori upregulates the expression of p16(INK4) in gastric cancer cells. | Hepatogastroenterology | 2011 May-Jun | Wang P | - |
| 22072122 | Nuclear co-expression of p14ARF and p16INK4A in uterine cervical cancer-derived cell lines containing HPV. | Cancer Biomark | 2010-2011 | V??zquez-Vega S | doi: 10.3233/CBM-2011-0223. |
| 25239644 | Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers. | Carcinogenesis | 2014 Dec | Li WQ | doi: 10.1093/carcin/bgu203 |
| 22126203 | Global DNA methylation and tumor suppressor gene promoter methylation and gastric cancer risk in an Omani Arab population. | Epigenomics | 2011 Aug | Rusiecki JA | doi: 10.2217/epi.11.65. |
| 23703248 | The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis. | Br J Cancer | 2013 Jun 25 | Xing X | doi: 10.1038/bjc.2013.251 |
| 16533425 | Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. | Neoplasia | 2006 Jan | Liu Y | - |
| 25344837 | Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues. | Carcinogenesis | 2015 Jan | Llanos AA | doi: 10.1093/carcin/bgu219 |
| 25640361 | HPV-associated p16 INK4A expression and response to therapy and survival in selected head and neck cancers. | Asian Pac J Cancer Prev | 2015 | Kanyilmaz G | - |
| 16799475 | Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression. | Mod Pathol | 2006 Oct | Zhang Z | - |
| 20082263 | Combined detection of p53, p16, Rb, and EGFR mutations in lung cancer by suspension microarray. | Genet Mol Res | 2009 Dec 23 | Ye Y | doi: 10.4238/vol8-4gmr627. |
| 26058606 | Increased phosphorylation on residue S795 of the retinoblastoma protein in esophageal adenocarcinoma. | Int J Oncol | 2015 Aug | Davelaar AL | doi: 10.3892/ijo.2015.3040 |
| 11992549 | Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer. | Int J Cancer | 2002 Jun 1 | Kudoh K | - |
| 20039540 | [Expression of p14(ARF) and E2F-1 in lung cancer in Gejiu and Xuanwei regions of Yunnan Province]. | Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi | 2009 Jul | Yang ZH | - |
| 25227142 | Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant. | Eur J Hum Genet | 2015 May | Potjer TP | doi: 10.1038/ejhg.2014.187 |
| 11839665 | Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients. | Clin Cancer Res | 2002 Feb | Chan MW | - |
| 23712779 | Promoter hypermethylation of tumour suppressor genes (p14/ARF and p16/INK4a): case-control study in North Indian population. | Mol Biol Rep | 2013 Aug | Askari M | doi: 10.1007/s11033-013-2592-5 |
| 25544647 | Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. | Radiother Oncol | 2014 Dec | Lassen P | doi: 10.1016/j.radonc.2014.11.032 |
| 23075891 | Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program. | Acta Cytol | 2012 | Gustinucci D | doi: 10.1159/000338979 |
| 23851489 | Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer. | Nat Cell Biol | 2013 Aug | Velimezi G | doi: 10.1038/ncb2795 |
| 26728683 | Bronchial lavage P 16INK4A gene promoter methylation and lung cancer diagnosis: A meta-analysis. | Indian J Cancer | 2015 Dec | Yifan D | doi: 10.4103/0019-509X.172522. |
| 19258477 | Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. | Cancer Epidemiol Biomarkers Prev | 2009 Mar | Goode EL | doi: 10.1158/1055-9965.EPI-08-0860 |
| 14985402 | Extending the p16-Leiden tumour spectrum by respiratory tract tumours. | J Med Genet | 2004 Mar | Oldenburg RA | - |
| 23504555 | Analysis of the methylation patterns of the p16 INK4A, p15 INK4B, and APC genes in gastric adenocarcinoma patients from a Brazilian population. | Tumour Biol | 2013 Aug | do Nascimento Borges B | doi: 10.1007/s13277-013-0742-y |
| 18613292 | Genetic testing in familial melanoma: uptake and implications. | Psychooncology | 2008 Aug | de Snoo FA | doi: 10.1002/pon.1377. |
| 12792748 | Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival. | Oncol Rep | 2003 Jul-Aug | Maeda K | - |
| 22106032 | Promoter methylation and loss of p16(INK4a) gene expression in head and neck cancer. | Head Neck | 2012 Oct | Demokan S | doi: 10.1002/hed.21949 |
| 22221586 | Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-nave prostate cancer. | J Negat Results Biomed | 2012 Jan 5 | Vlachostergios PJ | doi: 10.1186/1477-5751-11-2. |
| 24991542 | Promoter region hypermethylation and mRNA expression of MGMT and p16 genes in tissue and blood samples of human premalignant oral lesions and oral squamous cell carcinoma. | Biomed Res Int | 2014 | Bhatia V | doi: 10.1155/2014/248419 |
| 26457030 | Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity. | World J Gastroenterol | 2015 Oct 7 | Belgioia L | doi: 10.3748/wjg.v21.i37.10688. |
| 19584833 | DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus. | Am J Gastroenterol | 2009 Sep | Wang JS | doi: 10.1038/ajg.2009.300 |
| 21150883 | Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling. | Eur J Hum Genet | 2011 Apr | McWilliams RR | doi: 10.1038/ejhg.2010.198 |
| 25356972 | Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer. | Breast Cancer Res Treat | 2013 Jan | Rummel S | doi: 10.1007/s10549-012-2348-2 |
| 20459442 | Associations of risk factors obesity and occupational airborne exposures with CDKN2A/p16 aberrant DNA methylation in esophageal cancer patients. | Dis Esophagus | 2010 Sep | Mohammad Ganji S | doi: 10.1111/j.1442-2050.2010.01059.x |
| 12073046 | Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancer. | J Cancer Res Clin Oncol | 2002 Jun | Primdahl H | - |
| 20704749 | Combined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor genes on non small cell lung cancer: a hospital-based case-control study in China. | BMC Cancer | 2010 Aug 12 | Jin Y | doi: 10.1186/1471-2407-10-422. |
| 15824739 | Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. | Oncogene | 2005 Jun 9 | Schulmann K | - |
| 14719111 | Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications. | Int J Oncol | 2004 Feb | Gonz??lez-Quevedo R | - |
| 21287504 | [Relationship between promoter methylation of p16, DAPK and RAR beta genes and the clinical data of non-small cell lung cancer]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2011 Feb | Zhang CY | doi: 10.3760/cma.j.issn.1003-9406.2011.01.006. |
| 24344027 | Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma. | J BUON | 2013 Oct-Dec | Bar-Ad V | - |
| 18949413 | Quantitative p16 and ESR1 methylation in the peripheral blood of patients with non-small cell lung cancer. | Oncol Rep | 2008 Nov | Suga Y | - |
| 15146471 | Familial melanoma, pancreatic cancer and germline CDKN2A mutations. | Hum Mutat | 2004 Jun | Goldstein AM | - |
| 19571771 | Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer. | Melanoma Res | 2009 Aug | Nagore E | doi: 10.1097/CMR.0b013e3283281057. |
| 16222700 | p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients. | J Cell Physiol | 2006 Mar | Ulivi P | - |
| 18081229 | Two distinct pathways of p16 gene inactivation in gallbladder cancer. | World J Gastroenterol | 2007 Dec 21 | Tadokoro H | - |
| 26111702 | Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case-control study. | BMC Res Notes | 2015 Jun 26 | Potjer TP | doi: 10.1186/s13104-015-1235-4. |
| 24893334 | Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs. | Biochem Biophys Res Commun | 2014 Jul 18 | Kurayoshi K | doi: 10.1016/j.bbrc.2014.05.102 |
| 26335606 | Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers. | Br J Cancer | 2015 Sep 29 | Exner R | doi: 10.1038/bjc.2015.303 |
| 21717460 | Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer. | Int J Cancer | 2012 Jun 1 | Arima Y | doi: 10.1002/ijc.26271 |
| 24304703 | Doubling time calculations for lung cancer by three-dimensional computer-aided volumetry: effects of inter-observer differences and nodule characteristics. | J Med Imaging Radiat Oncol | 2014 Feb | Koike W | doi: 10.1111/1754-9485.12128 |
| 21225495 | High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx. | Pol J Pathol | 2010 | nietura M | - |
| 20697079 | Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. | J Clin Oncol | 2010 Sep 20 | Rischin D | doi: 10.1200/JCO.2010.29.2904 |
| 12883667 | Adenoviral p16/CDKN2 gene transfer to malignant glioma: role of p16 in growth, invasion, and senescence. | Oncol Rep | 2003 Sep-Oct | Kim SK | - |
| 23709347 | Detection of FHIT and p16 mRNA deletion in biopsy specimens obtained by bronchoscopy for the diagnosis of lung cancer. | Int J Biol Markers | 2013 Sep 27 | Chen P | doi: 10.5301/JBM.5000021. |
| 18334837 | Large-scale analysis of cell cycle regulators in urothelial bladder cancer identifies p16 and p27 as potentially useful prognostic markers. | Pathobiology | 2008 | Brunner A | doi: 10.1159/000113792 |
| 15879498 | A common variant of CDKN2A (p16) predisposes to breast cancer. | J Med Genet | 2005 Oct | Debniak T | - |
| 19372590 | p16 INK4A is a strong biomarker for cervical intraepithelial neoplasia and invasive cervical carcinoma: a reappraisal. | Reprod Sci | 2009 Jul | Haidopoulos D | doi: 10.1177/1933719109334259 |
| 24154929 | Identification of the methylation of p14ARF promoter as a novel non-invasive biomarker for early detection of lung cancer. | Clin Transl Oncol | 2014 Jun | Li L | doi: 10.1007/s12094-013-1122-1 |
| 22636603 | Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas. | J Med Genet | 2012 Jun | Harinck F | doi: 10.1136/jmedgenet-2011-100563 |
| 19468254 | p16ink4a is a surrogate marker for high-risk and malignant cervical lesions in the presence of human papillomavirus. | Pathobiology | 2009 May | Lakshmi S | doi: 10.1159/000209392 |
| 17650224 | Expression of p53, p16 and cyclooxygenase-2 in esophageal cancer with tissue microarray. | J Dig Dis | 2007 Aug | Liu YS | - |
| 17461444 | Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran. | World J Gastroenterol | 2007 Mar 14 | Abbaszadegan MR | - |
| 16828922 | The reduced expression and aberrant methylation of p16(INK4a) in chromate workers with lung cancer. | Lung Cancer | 2006 Sep | Kondo K | - |
| 21617221 | p16INK4a methylation in serum as a follow-up marker for recurrence of colorectal cancer. | Anticancer Res | 2011 May | Nakayama G | - |
| 19181545 | Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine. | Urol Oncol | 2010 Nov-Dec | Lin HH | doi: 10.1016/j.urolonc.2008.12.008 |
| 25188353 | Prognostic significance of overexpressed p16INK4a in patients with cervical cancer: a meta-analysis. | PLoS One | 2014 Sep 4 | Lin J | doi: 10.1371/journal.pone.0106384 |
| 23289480 | EZH2 regulates the expression of p16 in the nasopharyngeal cancer cells. | Technol Cancer Res Treat | 2013 Jun | Zhong J | doi: 10.7785/tcrt.2012.500315 |
| 23577085 | Association between P(16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis. | PLoS One | 2013 | Gu J | doi: 10.1371/journal.pone.0060107 |
| 23585871 | Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer. | PLoS One | 2013 Apr 9 | Amir S | doi: 10.1371/journal.pone.0061064 |
| 22483988 | PIWIL4 regulates cervical cancer cell line growth and is involved in down-regulating the expression of p14ARF and p53. | FEBS Lett | 2012 May 7 | Su C | doi: 10.1016/j.febslet.2012.03.053 |
| 16316628 | p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. | Biochem Biophys Res Commun | 2006 Jan 20 | Kawamoto K | - |
| 14729628 | p53 activation in chronic radiation-treated breast cancer cells: regulation of MDM2/p14ARF. | Cancer Res | 2004 Jan 1 | Xia L | - |
| 25053593 | Meta-analyses of methylation markers for prostate cancer. | Tumour Biol | 2014 Oct | Jiang D | doi: 10.1007/s13277-014-2300-7 |
| 26338139 | Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer. | Sci Rep | 2015 Sep 4 | Tang B | doi: 10.1038/srep13563. |
| 25417611 | Promoter hypermethylation of p16 and APC in gastrointestinal cancer patients. | Turk J Gastroenterol | 2014 Oct | Erdem B | doi: 10.5152/tjg.2014.4791. |
| 25439690 | HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. | Lancet Oncol | 2014 Nov | Ndiaye C | doi: 10.1016/S1470-2045(14)70471-1 |
| 20360646 | [Value of promoter methylation of RASSF1A, p16, and DAPK genes in induced sputum in diagnosing lung cancers]. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2010 Mar | Peng Z | doi: 10.3969/j.issn.1672-7347.2010.03.010. |
| 27509952 | Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer. | Asian Pac J Cancer Prev | 2016 | Kanthiya K | - |
| 15059516 | [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines]. | Zhonghua Yi Xue Za Zhi | 2004 Feb 17 | Chen YX | - |
| 27468574 | Detecting of p16 Autoantibody as a Potential Early Diagnostic Serum Biomarker in Patients with Cervical Cancer. | Clin Lab | 2016 | Huangfu M | - |
| 11960384 | Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells. | Oncogene | 2002 Mar 27 | Katsuda K | - |
| 17466040 | p16(CDKN2) gene polymorphism: association with histologic subtypes of epithelial ovarian cancer in China. | Int J Gynecol Cancer | 2008 Jan-Feb | Yan L | - |
| 24529061 | Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer. | J Med Imaging Radiat Oncol | 2014 Feb | Trinkaus ME | doi: 10.1111/1754-9485.12155. |
| 24096545 | QM-FISH analysis of the genes involved in the G1/S checkpoint signaling pathway in triple-negative breast cancer. | Tumour Biol | 2014 Mar | Zhang S | doi: 10.1007/s13277-013-1246-5 |
| 17106238 | Detecting low-abundance p16 and p53 mutations in pancreatic juice using a novel assay: heteroduplex analysis of limiting dilution PCRs. | Cancer Biol Ther | 2006 Oct | Bian Y | - |
| 12684640 | Epigenetic changes of tumor suppressor genes, P15, P16, VHL and P53 in oral cancer. | Oncol Rep | 2003 May-Jun | Yeh KT | - |
| 15378017 | Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice. | Oncogene | 2004 Oct 28 | Mart??n-Caballero J | - |
| 26339389 | Expression of p16 and pRB in invasive breast cancer. | Int J Clin Exp Pathol | 2015 Jul 1 | Shin E | - |
| 18752124 | p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types. | Pathology | 2008 Oct | Lam AK | doi: 10.1080/00313020802320713. |
| 12918069 | Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer. | Int J Cancer | 2003 Oct 10 | Jarmalaite S | - |
| 18283637 | Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factor. | Histol Histopathol | 2008 May | Surowiak P | doi: 10.14670/HH-23.531. |
| 12853838 | Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer. | J Urol | 2003 Aug | Chang LL | - |
| 22820083 | Concurrent alteration of p16 and PTEN tumor suppressor genes could be considered as potential molecular marker for specific subgroups of NSCLC patients. | Cancer Biomark | 2011-2012 | Andjelkovic T | doi: 10.3233/CBM-2012-0257. |
| 26198641 | STAT3 regulated ARF expression suppresses prostate cancer metastasis. | Nat Commun | 2015 Jul 22 | Pencik J | doi: 10.1038/ncomms8736. |
| 20338046 | DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response. | Mol Cancer | 2010 Mar 25 | Dejeux E | doi: 10.1186/1476-4598-9-68. |
| 23449888 | ARF represses androgen receptor transactivation in prostate cancer. | Mol Endocrinol | 2013 Apr | Lu W | doi: 10.1210/me.2012-1294 |
| 24935963 | High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families. | J Med Genet | 2014 Aug | Helgadottir H | doi: 10.1136/jmedgenet-2014-102320 |
| 11869517 | [A study on homozygous deletion, hypermethylation, mutation and expression of p16 gene in human breast cancer]. | Zhonghua Bing Li Xue Za Zhi | 1999 Apr | Guo S | - |
| 25693938 | The relationship between P16 gene promoter methylation and gastric cancer: a meta-analysis based on Chinese patients. | J Cancer Res Ther | 2014 Dec | Peng D | doi: 10.4103/0973-1482.151535. |
| 25544708 | Correlation between squamous cell carcinoma of the lung and human papillomavirus infection and the relationship to expression of p53 and p16. | Tumour Biol | 2015 Apr | Fan X | doi: 10.1007/s13277-014-2940-7 |
| 12169206 | MYCL1, FHIT, SPARC, p16(INK4) and TP53 genes associated to lung cancer in idiopathic pulmonary fibrosis. | J Cell Mol Med | 2002 Apr-Jun | Demopoulos K | - |
| 21621871 | Expression of p16 in non-small cell lung cancer and its prognostic significance: a meta-analysis of published literatures. | Lung Cancer | 2011 Nov | Tong J | doi: 10.1016/j.lungcan.2011.04.019 |
| 14719099 | Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer. | Int J Oncol | 2004 Feb | Paradiso A | - |
| 15492852 | Alteration of the MDM2-p73-P14ARF pathway related to tumour progression during urinary bladder carcinogenesis. | Int J Mol Med | 2004 Nov | Schlott T | - |
| 20032395 | Numerical abnormalities of chromosome 9 and p16CDKN2A gene deletion detected by FISH in non-small cell lung cancer. | Anticancer Res | 2009 Nov | Panani AD | - |
| 16675157 | Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer. | Pathol Res Pract | 2006 | Lee M | - |
| 12454511 | CDKN2A germline mutations in familial pancreatic cancer. | Ann Surg | 2002 Dec | Bartsch DK | - |
| 20423915 | p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. | Ann Oncol | 2010 Oct | Fischer CA | doi: 10.1093/annonc/mdq210 |
| 17198183 | K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking. | Pancreas | 2007 Jan | Jiao L | - |
| 20372796 | Carcinogenesis and cellular immortalization without persistent inactivation of p16/Rb pathway in lung cancer. | Int J Oncol | 2010 May | Arifin M | - |
| 26381259 | Germline CDKN2A mutations in childhood melanoma: a case of melanoma-pancreatic cancer syndrome. | Int J Dermatol | 2015 Dec | Gironi LC | doi: 10.1111/ijd.12933 |
| 23034738 | Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer. | Int J Cancer | 2013 May 1 | Han SW | doi: 10.1002/ijc.27888 |
| 20581473 | Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM). | Cancer Biol Ther | 2010 Sep 15 | Carter H | - |
| 20800513 | Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection. | Urol Oncol | 2012 Mar-Apr | Lin HH | doi: 10.1016/j.urolonc.2010.01.002 |
| 21777578 | The risk factor of gallbladder cancer: hyperplasia of mucous epithelium caused by gallstones associates with p16/CyclinD1/CDK4 pathway. | Exp Mol Pathol | 2011 Oct | Feng Z | doi: 10.1016/j.yexmp.2011.06.004 |
| 17885492 | The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma. | Int J Gynecol Pathol | 2007 Oct | Khouja MH | - |
| 21297668 | p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors. | Oncogene | 2011 May 5 | Romagosa C | doi: 10.1038/onc.2010.614 |
| 11889694 | [Expression of the protein marker p16INK4a in the cervix uteri cancer]. | Arkh Patol | 2002 Jan-Feb | Volgareva GM | - |
| 26457819 | The Correlation Relationship between P14ARF Gene DNA Methylation and Primary Liver Cancer. | Med Sci Monit | 2015 Oct 12 | Zhang H | doi: 10.12659/MSM.894395. |
| 21619050 | Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. | Biochemistry | 2011 Jun 28 | Li J | doi: 10.1021/bi200642e |
| 21487939 | OVCA1 inhibits the proliferation of epithelial ovarian cancer cells by decreasing cyclin D1 and increasing p16. | Mol Cell Biochem | 2011 Aug | Kong F | doi: 10.1007/s11010-011-0819-0 |
| 26514498 | Association between p16 Promoter Methylation and Thyroid Cancer Risk: A Meta-analysis. | Asian Pac J Cancer Prev | 2015 | Wu W | - |
| 23336272 | The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer. | Breast Cancer Res | 2013 Jan 21 | Peurala E | doi: 10.1186/bcr3376. |
| 24710824 | Frequency of genetic and epigenetic alterations of p14ARF and p16INK4A in head and neck cancer in a Hungarian population. | Pathol Oncol Res | 2014 Oct | Kis A | doi: 10.1007/s12253-014-9775-9 |
| 20549016 | MTHFR, MTR, and MTRR polymorphisms in relation to p16INK4A hypermethylation in mucosa of patients with colorectal cancer. | Mol Med | 2010 Sep-Oct | Wettergren Y | doi: 10.2119/molmed.2009.00156 |
| 22344043 | p16 gene alterations in human ovarian cancers: comparison between tissue and blood samples. | Int J Gynecol Cancer | 2012 May | Bammidi LS | doi: 10.1097/IGC.0b013e31823fa90c. |
| 21278246 | Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer. | Clin Cancer Res | 2011 Mar 15 | Konecny GE | doi: 10.1158/1078-0432.CCR-10-2307 |
| 23128528 | DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients. | Int J Oncol | 2013 Jan | Nilsson TK | doi: 10.3892/ijo.2012.1682 |
| 21054888 | Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc. | BMC Cancer | 2010 Nov 6 | Gao FH | doi: 10.1186/1471-2407-10-610. |
| 23111194 | CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients. | Diagn Mol Pathol | 2012 Dec | Bradly DP | doi: 10.1097/PDM.0b013e31825554b2. |
| 19375815 | p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos. | Lung Cancer | 2010 Jan | Andujar P | doi: 10.1016/j.lungcan.2009.03.018. |
| 27591832 | Chemotherapy and Stem Cell Transplantation Increase p16INK4a Expression, a Biomarker of T-cell Aging. | EBioMedicine | 2016 Sep | Wood WA | doi: 10.1016/j.ebiom.2016.08.029 |
| 19506903 | RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China. | J Cancer Res Clin Oncol | 2009 Dec | Lin Q | doi: 10.1007/s00432-009-0614-4 |
| 12824886 | Detection of p16 promoter hypermethylation in serum of gastric cancer patients. | Cancer Sci | 2003 May | Kanyama Y | - |
| 27573859 | MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways. | Oncol Rep | 2016 Oct | Shin SS | doi: 10.3892/or.2016.5052 |
| 18243403 | Retrospective analysis of the prognostic role of p16 protein inactivation in plasma in patients with locally advanced non-small cell lung cancer. | Lung Cancer | 2008 Jul | Sirera R | doi: 10.1016/j.lungcan.2007.12.005 |
| 24837742 | Methylation of CpG island of p14(ARK), p15(INK4b) and p16(INK4a) genes in coke oven workers. | Hum Exp Toxicol | 2015 Feb | Zhang H | doi: 10.1177/0960327114533576 |
| 11807902 | High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families. | Am J Med Genet | 2002 Jan 22 | Mantelli M | - |
| 20013810 | Nerve invasion distance is dependent on laminin gamma2 in tumors of pancreatic cancer. | Int J Cancer | 2010 Aug 15 | Mitsunaga S | doi: 10.1002/ijc.25104. |
| 15447998 | Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer. | Clin Cancer Res | 2004 Sep 15 | Wang J | - |
| 12200117 | Recombinant adenovirus-mediated p14(ARF) overexpression sensitizes human breast cancer cells to cisplatin. | Biochem Biophys Res Commun | 2002 Aug 30 | Deng X | - |
| 15502810 | p16INK4A and p14ARF expression pattern by immunohistochemistry in human papillomavirus-related cervical neoplasia. | Mod Pathol | 2005 May | Wang JL | - |
| 18619950 | Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide. | Chem Biol Interact | 2008 Aug 11 | Shi MD | doi: 10.1016/j.cbi.2008.06.006 |
| 18239974 | Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma. | Ann Surg Oncol | 2008 Apr | Sinha S | doi: 10.1245/s10434-007-9790-0 |
| 22134685 | MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patients with lung cancer and non-malignant lung diseases. | Oncol Rep | 2012 Apr | Shin KC | doi: 10.3892/or.2011.1566 |
| 11733969 | Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53. | Gynecol Oncol | 2001 Dec | Ramirez PT | - |
| 21728901 | Methylation status of the gene promoter of cyclin-dependent kinase inhibitor 2A (CDKN2A) in ovarian cancer. | Scand J Clin Lab Invest | 2011 Nov | Abou-Zeid AA | doi: 10.3109/00365513.2011.590224 |
| 26843058 | Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome. | Histopathology | 2016 Sep | Pare R | doi: 10.1111/his.12948 |
| 27716889 | Establishment of two data mining models of lung cancer screening based on three gene promoter methylations combined with telomere damage. | Int J Biol Markers | 2017 Mar 2 | Wang W | doi: 10.5301/jbm.5000232. |
| 27449771 | Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations. | Hum Genet | 2016 Nov | Yang XR | - |
| 27428416 | Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer. | EBioMedicine | 2016 Jun | Zhao R | doi: 10.1016/j.ebiom.2016.04.017 |
| 27761872 | Correlation between indoleamine 2,3 dioxygenase mRNA and CDKN2A/p16 mRNA: a combined strategy to cervical cancer diagnosis. | Med Oncol | 2016 Nov | Saffi Junior MC | - |
| 27648827 | Association between P16INK4a Promoter Methylation and Ovarian Cancer: A Meta-Analysis of 12 Published Studies. | PLoS One | 2016 Sep 20 | Xiao X | doi: 10.1371/journal.pone.0163257 |
| 28700487 | Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA. | Medicine (Baltimore) | 2017 Jul | Sheng X | doi: 10.1097/MD.0000000000007476. |
| 28395715 | [Subcellular re-distribution of F-actin in MCF7 cells upon inducible expression of CDKN2A/p16INK4a]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2017 Apr | Liang J | - |
| 28319413 | Aberrant promoter hypermethylation of p16, survivin, and retinoblastoma in gastric cancer. | Bratisl Lek Listy | 2017 | Guo L | doi: 10.4149/BLL_2017_033. |
| 28074012 | Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer. | Sci Signal | 2017 Jan 10 | Gamell C | doi: 10.1126/scisignal.aaf8223. |
| 28466822 | The effects of CDKN2A rs3731249, rs11515, and rs3088440 polymorphisms on cancer risk. | Cell Mol Biol (Noisy-le-grand) | 2017 Mar 31 | Dong Y | doi: 10.14715/cmb/2017.63.3.8. |
| 27835607 | p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer. | Oncotarget | 2016 Dec 6 | Lebok P | doi: 10.18632/oncotarget.13227. |
| 29254312 | p16 gene expression in pancreatic cancer tissue and its importance in diagnosis. | J Biol Regul Homeost Agents | 2017 Oct-Dec | Mou H | - |
| 27486979 | Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. | Oncotarget | 2016 Aug 30 | Campa D | doi: 10.18632/oncotarget.10935. |
| 27588487 | p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China. | Oncotarget | 2016 Oct 4 | Yu LL | doi: 10.18632/oncotarget.11705. |
| 28412731 | C-terminal binding protein-2 promotes cell proliferation and migration in breast cancer via suppression of p16INK4A. | Oncotarget | 2017 Apr 18 | Yang X | doi: 10.18632/oncotarget.15402. |
| 28445153 | Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes. | Oncotarget | 2017 Jun 6 | Furet E | doi: 10.18632/oncotarget.16953. |
| 28730335 | Clinical and prognosis value of the CIMP status combined with MLH1 or p16 INK4a methylation in colorectal cancer. | Med Oncol | 2017 Aug | Saadallah-Kallel A | doi: 10.1007/s12032-017-1007-1 |
| 28737694 | The Role of p16INK4a Pathway in Human Epidermal Stem Cell Self-Renewal, Aging and Cancer. | Int J Mol Sci | 2017 Jul 22 | D'Arcangelo D | doi: 10.3390/ijms18071591. |
| 28662664 | Dual role for p16 in the metastasis process of HPV positive head and neck cancers. | Mol Cancer | 2017 Jun 29 | Dok R | doi: 10.1186/s12943-017-0678-8. |
| 29561434 | Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA). | Medicine (Baltimore) | 2018 Mar | Cao Z | doi: 10.1097/MD.0000000000010182. |
| 28592523 | Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma. | J Med Genet | 2017 Sep | Jouenne F | doi: 10.1136/jmedgenet-2016-104402 |
| 28939073 | Role of CDKN2A/p16 expression in the prognostication of oral squamous cell carcinoma. | Oral Oncol | 2017 Oct | Padhi SS | doi: 10.1016/j.oraloncology.2017.07.030 |
| 29895125 | Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer. | Pol J Pathol | 2018 | Celewicz A | doi: 10.5114/pjp.2018.75335. |
| 29758205 | Performance of P16/Ki67 dual staining in triaging hr-HPV-positive population during cervical Cancer screening in the younger women. | Clin Chim Acta | 2018 Aug | Qian QP | doi: 10.1016/j.cca.2018.05.023 |
| 29228217 | p19Arf inhibits aggressive progression of H-ras-driven hepatocellular carcinoma. | Carcinogenesis | 2018 Mar 8 | Kopanja D | doi: 10.1093/carcin/bgx140. |
| 30060056 | Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription. | Acta Biochim Biophys Sin (Shanghai) | 2018 Sep 1 | Zheng Q | doi: 10.1093/abbs/gmy084. |
| 30059872 | In situ expressions of protein 16 (p16CDKN2A) and transforming growth factor beta-1 in patients with cervical intraepithelial neoplasia and cervical cancer. | Eur J Obstet Gynecol Reprod Biol | 2018 Sep | Viloria ME | doi: 10.1016/j.ejogrb.2018.07.023 |
| 30150594 | Low P16INK4A Expression Associated with High Expression of Cancer Stem Cell Markers Predicts Poor Prognosis in Cervical Cancer after Radiotherapy. | Int J Mol Sci | 2018 Aug 27 | Fu HC | doi: 10.3390/ijms19092541. |
| 30310820 | Association of p16 as Prognostic Factors for Oropharyngeal Cancer: Evaluation of p16 in 1470 Patients for a 16 Year Study in Northeast China. | Biomed Res Int | 2018 Sep 17 | Meng HX | doi: 10.1155/2018/9594568 |
| 29283500 | Identification of a novel nucleophosmin-interaction motif in the tumor suppressor p14arf. | FEBS J | 2018 Mar | Luchinat E | doi: 10.1111/febs.14373 |
| 29543703 | CDKN2A germline alterations in melanoma patients with personal or familial history of pancreatic cancer. | Melanoma Res | 2018 Jun | De Unamuno B | doi: 10.1097/CMR.0000000000000442. |
| 30348132 | The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging. | BMC Cancer | 2018 Oct 22 | Ye X | doi: 10.1186/s12885-018-4921-5. |
| 29525349 | High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma. | Clin Genitourin Cancer | 2018 Aug | Breyer J | doi: 10.1016/j.clgc.2018.01.009 |
| 29927090 | P16INK4a gene promoter methylation as a biomarker for the diagnosis of non-small cell lung cancer: An updated meta-analysis. | Thorac Cancer | 2018 Aug | Tuo L | doi: 10.1111/1759-7714.12783 |
| 28910940 | [Diagnostic value of p16/mcm2 dual staining in cervical intraepithelial neoplasia and its association with high-risk HPV infection]. | Zhonghua Liu Xing Bing Xue Za Zhi | 2017 Sep 10 | Wang HR | doi: 10.3760/cma.j.issn.0254-6450.2017.09.020. |
| 30039340 | CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis. | Breast Cancer | 2019 Jan | Aftab A | doi: 10.1007/s12282-018-0894-0 |
